CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- 8-K/A Event Exhibits
- 4 Open-market sale Director sold 2,409 shares at $2.00 ($4,818)
- 4 Open-market sale Chief Scientific Officer sold 582,023 shares at $2.08 ($1,213,402)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Exhibits
- 4 Open-market buy Executive VP, CFO & COO bought 500 shares at an average $3.28 ($1,638)
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy Director bought 433 shares at an average $2.88 ($1,247)
- 4 Open-market buy Director bought 2,000 shares at $3.19 ($6,380)
- 10-Q Report Quarterly Report
Page 7 of 19 · 368 filings